Science Explorer Back to mapMap
Discussion
Researcher · Novo Nordisk (Denmark) · Denmark

Steffen Reedtz‐Runge

Steffen Reedtz‐Runge publishes mostly in Molecular Biology, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism, on topics such as Receptor Mechanisms and Signaling, Neuropeptides and Animal Physiology and Diabetes Treatment and Management.

ORCID 0000-0002-9216-3311 OpenAlex
World rank
#383,478
of 7,710,434 ranked researchers
Rank in Denmark
#2,766
of 43,819
Works
32
Citations
3.9k
Citations per work
121.1
h-index
18
i10-index 22Top 39% in Molecular Biology
Steffen Reedtz‐Runge

What does Steffen Reedtz‐Runge research?

Steffen Reedtz‐Runge's work is mostly in Biochemistry, Genetics and Molecular Biology (38%), Medicine (33%), Neuroscience (23%).

Life Sciences: 20 works · 61.6% of their workBiochemistry, Genetics and Molecular Biology: 12 works · 38.5% of their workMolecular Biology: 12 works · 38.5% of their workNeuroscience: 7 works · 23.1% of their workCellular and Molecular Neuroscience: 7 works · 23.1% of their workHealth Sciences: 11 works · 33.4% of their workMedicine: 11 works · 33.4% of their workEndocrinology, Diabetes and Metabolism: 6 works · 19.2% of their workSurgery: 3 works · 9.0% of their workOncology: 1 works · 2.6% of their workRadiology, Nuclear Medicine and Imaging: 1 works · 2.6% of their workEverything else: 2 works · 5.0% of their workTHEIR WORKSteffenReedtz‐Runge32works
Life Sciences62%Health Sciences33%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1238.5%
    2. Neuroscience723.1%
    1. Medicine1133.4%
  3. Everything else25.0%
  1. 1Molecular Biology38% of their works
  2. 2Cellular and Molecular Neuroscience23% of their works
  3. 3Endocrinology, Diabetes and Metabolism19% of their works
  4. 4Surgery9% of their works
  5. 5Radiology, Nuclear Medicine and Imaging3% of their works
  6. 6Oncology3% of their works

Research topics

Which keywords describe Steffen Reedtz‐Runge's research?

The keywords of their largest research topics: Crystal Structure, G-Protein-Coupled Receptors, Neuropeptides, Receptors, Cardiovascular Outcomes, Type 2 Diabetes, Pancreatic Islets and ß-Cell Dysfunction.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 16 words, with their numbers
  1. Crystal Structure201 topic
  2. G-Protein-Coupled Receptors201 topic
  3. Neuropeptides181 topic
  4. Receptors181 topic
  5. Cardiovascular Outcomes151 topic
  6. Type 2 Diabetes151 topic
  7. Pancreatic Islets61 topic
  8. ß-Cell Dysfunction61 topic
  9. Calcineurin31 topic
  10. NFAT31 topic
  11. AMP-Activated Protein Kinase21 topic
  12. Fc Receptors21 topic
  13. Fibroblast Activation Protein21 topic
  14. Metformin21 topic
  15. Therapeutic Antibodies21 topic
  16. Tumor Microenvironment21 topic

Where does Steffen Reedtz‐Runge work?

Steffen Reedtz‐Runge's main affiliation in the publication record is Novo Nordisk (Denmark), Denmark.

How many publications and citations does Steffen Reedtz‐Runge have?

OpenAlex counts 32 works and 3,875 citations for Steffen Reedtz‐Runge, an h-index of 18, ranking #383,478 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Steffen Reedtz‐Runge. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.